The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

About Tissue Regeneration Technologies

Tissue Regeneration Technologies is a medical device company developing: Extracorporeal Shockwaves, Extracorporeal shock wave therapy.Tissue Regeneration Technologies, LLC (TRT), is a global medical technology company founded in 2004 and headquartered in Woodstock, Georgia (near Atlanta). ; We develop, manufacture and sell devices used primarily in Urology, Orthopedics and in Wound Care. ; Currently, we employ about 30 people in the USA, Germany and Switzerland.

Tissue Regeneration Technologies Headquarter Location

1319 F St Nw # 900

Washington, DC, 20004,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Tissue Regeneration Technologies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Tissue Regeneration Technologies is included in 4 Expert Collections, including Medical Devices.


Medical Devices

11,367 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).



1,750 items


Health IT

7,900 items

Tissue Regeneration Technologies Patents

Tissue Regeneration Technologies has filed 5 patents.

The 3 most popular patent topics include:

  • Acoustics
  • Aerodynamics
  • Shock waves
patents chart

Application Date

Grant Date


Related Topics




Electronic circuit simulators, Energy storage, Capacitors, Solid state switches, Electronic circuits


Application Date


Grant Date



Related Topics

Electronic circuit simulators, Energy storage, Capacitors, Solid state switches, Electronic circuits



Latest Tissue Regeneration Technologies News

SoftWave Tissue Regeneration Technologies Enters Exclusive Distribution Agreement With Cynosure to Sell Technology in the Aesthetics and Sexual Health Markets

Dec 22, 2021

12/22/2021 | 12:01pm EST Message : Exclusive North American Agreement ATLANTA, Dec. 22, 2021 (GLOBE NEWSWIRE) -- SoftWave Tissue Regeneration Technologies (SoftWave TRT) announced an exclusive agreement to supply Cynosure LLC, a global leader in medical aesthetics, with its patented extracorporeal shock wave devices for distribution in the United States and Canada primarily to medical doctors and their practices. "This agreement substantially increases doctors' and patients' access to our FDA cleared technology to accelerate healing, improve blood supply, activate connective tissue and to reduce pain and inflammation by leveraging Cynosure's impeccable reputation and extensive sales force and marketing team," says John Warlick, CEO of SoftWave Tissue Regeneration Technologies. "This agreement should quadruple our installed base over the next three years and provide extraordinary outcomes and benefits. This partnership will also allow Softwave TRT to focus our efforts on other fields of use, including Alzheimer's, reduced opioid consumption, and cardiology and wound care," he says. SoftWave's patented, unique technology triggers the body's own biological healing response. In contrast to competitors' shockwave devices, SoftWave TRT devices offer a non-invasive procedure and require no anesthesia or numbing agents. The patented SoftWave TRT technology deploys an unfocused extracorporeal shockwave (uESWT) that promotes both a physical and biological response to accelerate healing and tissue regeneration. The patented parabolic reflector produces a wider and deeper therapeutic energy zone resulting in reduced pain and superior patient outcomes by increasing blood supply, modulating inflammation, and stimulating, activating and recruiting resident and mesenchymal cells as described in published peer-reviewed research ( About SoftWave Tissue Regeneration Technologies SoftWave Tissue Regeneration Technologies, LLC is a medical technology company specializing in unfocused, electrohydraulically generated shockwave therapy (SoftWave) and other advanced solutions for inflammatory modulation, stem cell activation and recruitment, and antibacterial and antiviral responses. The company's extracorporeal SoftWave device (the "OrthoGold") is FDA 510(k) cleared for the activations of connective tissues, treatment of chronic diabetic foot ulcers, treatment of acute second-degree burns, pain reduction and improved blood supply. The company is also researching the effectiveness of SoftWave technology in the treatment of spinal trauma, Alzheimer's, and dementia. Headquartered in Woodstock, Ga, SoftWave TRT technology is used worldwide in the fields of orthopedics,  traumatology, wound care, aesthetics, cardiology, urology, and neurology. Contact: or (888) 862-6162 Twitter: @SoftwaveTRT

Tissue Regeneration Technologies Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Tissue Regeneration Technologies Rank

  • Where is Tissue Regeneration Technologies's headquarters?

    Tissue Regeneration Technologies's headquarters is located at 1319 F St Nw, Washington.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.